MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 70 filers reported holding MONTE ROSA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $109,980 | -2.7% | 15,600 | -22.0% | 0.00% | – |
| Q4 2023 | $113,000 | -63.9% | 20,000 | -69.4% | 0.00% | – |
| Q3 2023 | $313,041 | -14.9% | 65,353 | +21.6% | 0.00% | – |
| Q2 2023 | $368,044 | +40.4% | 53,729 | +59.7% | 0.00% | – |
| Q1 2023 | $262,048 | +23.5% | 33,639 | +20.7% | 0.00% | – |
| Q4 2022 | $212,114 | +17.2% | 27,873 | +25.5% | 0.00% | – |
| Q3 2022 | $181,000 | +84.7% | 22,213 | +120.4% | 0.00% | – |
| Q2 2022 | $98,000 | – | 10,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $32,804,000 | 6.54% |
| Cormorant Asset Management, LP | 3,102,199 | $67,957,000 | 2.76% |
| NEA Management Company, LLC | 7,703,205 | $171,627,000 | 2.04% |
| Avoro Capital Advisors LLC | 3,311,434 | $61,003,000 | 0.96% |
| Octagon Capital Advisors LP | 150,000 | $3,342,000 | 0.82% |
| Alphabet Inc. | 1,464,015 | $32,618,000 | 0.77% |
| Casdin Capital, LLC | 960,883 | $21,408,000 | 0.53% |
| RTW INVESTMENTS, LP | 1,214,572 | $26,005,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 119,647 | $2,666,000 | 0.22% |
| Avidity Partners Management LP | 300,000 | $6,684,000 | 0.15% |